Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 17Tumor-Agnostic 15Other hematologic neoplasm 13Plasma cell 12Thoracic 10Lymphoid 8Breast 7Gynecologic 4Sarcoma 3Genitourinary 3Dermatologic 3Head & Neck 2NET 1Endocrine 1CNS 1

Conditions

Neuroendocrine Tumors 130Gastro-enteropancreatic neuroendocrine tumor 16Pancreatic Neoplasms 14Neoplasms 12Stomach Neoplasms 8Carcinoma, Neuroendocrine 8Carcinoid Tumor 8Prostatic Neoplasms 7Lung Neoplasms 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Thyroid Neoplasms 6Melanoma 6Esophageal Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Pheochromocytoma 5Neoplasm Metastasis 5Gastrointestinal Stromal Tumors 5Carcinoma 5Adenoma, Islet Cell 5Adenocarcinoma 5Testicular Neoplasms 4Skin Neoplasms 4Serotonin Syndrome 4Sarcoma 4Paraganglioma 4Liver Neoplasms 4Kidney Neoplasms 4Head and Neck Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Neoplasm, Residual × NET × Clear all
NCT05196087 2025-07-02

NIP IT!

University Health Network, Toronto

Recruiting
500 enrolled
BreastDermatologicEndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Breast Neoplasms, Melanoma, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡